We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$535M
AUM Growth
+$69.3M
(+15%)
Cap. Flow
+$21.1M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
688
New
58
Increased
157
Reduced
267
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$60M |
| 2 |
PepsiCo
PEP
|
+$9.31M |
| 3 |
TechnipFMC
FTI
|
+$8.19M |
| 4 |
WisdomTree India Earnings Fund ETF
EPI
|
+$7.88M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$14.4M |
| 2 |
Stellantis
STLA
|
+$8.39M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$7.31M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$6.57M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$6.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.57% |
| 2 | Technology | 5.11% |
| 3 | Consumer Discretionary | 4.59% |
| 4 | Materials | 4.47% |
| 5 | Energy | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Avery Dennison
AVY
$12.3B
| $1.84M | 0.34% |
18,710
+18,707
| +623,567% | +$1.76M |
|
52
SS&C Technologies
SSNC
$17.8B
| $1.82M | 0.34% |
45,454
+44,976
| +9,409% | +$1.74M |
|
|
HBI
53
DELISTED
Hanesbrands
HBI
| $1.82M | 0.34% |
74,037
+65,806
| +799% | +$1.58M |
|
54
Motorola Solutions
MSI
$69.4B
| $1.82M | 0.34% |
21,395
+19,782
| +1,226% | +$1.73M |
|
55
Microchip Technology
MCHP
$42.8B
| $1.82M | 0.34% |
40,446
-10,438
| -21% | -$438K |
|
56
Toronto Dominion Bank
TD
$198B
| $1.81M | 0.34% |
32,000
| – | – |
|
57
Constellation Brands
STZ
$22.2B
| $1.77M | 0.33% |
8,889
+8,303
| +1,417% | +$1.64M |
|
58
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $1.76M | 0.33% |
16,536
+40
| +0.2% | +$4.29K |
|
59
Fidelity National Information Services
FIS
$21.5B
| $1.76M | 0.33% |
18,836
+18,835
| +1,883,500% | +$1.71M |
|
60
Global Payments
GPN
$22.1B
| $1.75M | 0.33% |
+18,381
| New | +$1.73M |
|
61
PVH
PVH
$3.71B
| $1.7M | 0.32% |
+13,492
| New | +$1.64M |
|
62
Ingredion
INGR
$6.38B
| $1.69M | 0.32% |
14,049
+14,046
| +468,200% | +$1.71M |
|
63
Royal Caribbean
RCL
$78.7B
| $1.67M | 0.31% |
14,097
-3,635
| -20% | -$425K |
|
64
Global X Uranium ETF
URA
$5.52B
| $1.56M | 0.29% |
117,078
+9,695
| +9% | +$134K |
|
65
Bank of America
BAC
$435B
| $1.51M | 0.28% |
59,438
+1,678
| +3% | +$40.7K |
|
66
Kinder Morgan
KMI
$73.1B
| $1.5M | 0.28% |
78,342
+52,706
| +206% | +$1.03M |
|
|
67
CALL
TechnipFMC
FTI
$30.6B
| $1.5M | 0.28% |
6,465
-5,365
| -45% | -$108K |
|
|
68
PUT
TechnipFMC
FTI
$30.6B
| $1.5M | 0.28% |
12,647
+7,256
| +135% | +$146K |
|
69
Bank of Montreal
BMO
$125B
| $1.44M | 0.27% |
18,975
-11,500
| -38% | -$858K |
|
|
GG
70
DELISTED
Goldcorp Inc
GG
| $1.41M | 0.26% |
108,497
-1,182
| -1% | -$15.5K |
|
71
Healthpeak Properties
DOC
$15.4B
| $1.4M | 0.26% |
50,235
+6,731
| +15% | +$202K |
|
72
AngloGold Ashanti
AU
$40.3B
| $1.35M | 0.25% |
145,754
+102,336
| +236% | +$990K |
|
73
Petrobras
PBR
$121B
| $1.31M | 0.25% |
130,835
-14,503
| -10% | -$132K |
|
74
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $1.3M | 0.24% |
11,200
+4,459
| +66% | +$515K |
|
75
Gilead Sciences
GILD
$161B
| $1.27M | 0.24% |
15,651
-311
| -2% | -$23.8K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2017 Portfolio in Review
As of Q3 2017, Exane Derivatives held 688 positions worth $535M, up 15% from $466M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Exane Derivatives deployed $21.1M of net new capital in Q3 2017, opening 58 new positions and adding to 157 existing holdings. Its largest new stake was PepsiCo: 80,581 shares worth $8.98M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Deutsche Bank, an estimated $14.4M trimmed.
- Exane Derivatives's largest Q3 2017 buy was PepsiCo: 80,581 shares worth $8.98M.
- Exane Derivatives added most to UBS Group in Q3 2017, an estimated $60M increase.
- Exane Derivatives's biggest Q3 2017 reduction was Deutsche Bank, cutting an estimated $14.4M.
- Exane Derivatives fully exited Stellantis in Q3 2017, selling an estimated $8.39M.
- Exane Derivatives's ten largest holdings make up 50% of its $535M portfolio in Q3 2017.
- Exane Derivatives opened 58 new positions and closed 121 in Q3 2017.
- Exane Derivatives's portfolio value rose 15% quarter-over-quarter to $535M.
Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.